Genomic & Biopharma News

Researchers repurpose diabetes drug for brain pressure
Research led by the University of Birmingham indicates that a GLP-1 agonist drug, currently used to lower blood sugar in people with type II diabetes, could be repurposed to treat raised brain pressure.
PharmaTimes, 2017-08-24 07:35:27

Merck sees promise in Macrophage Pharma
Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
PharmaTimes, 2017-08-24 07:19:30

Extended use of AZ’ Brilinta cuts CV death risk 29%
Long-term use of AstraZeneca’s Brilinta in patients with a history of heart attack reduces the risk of cardiovascular death by 29 percent, a new sub analysis of data from the Phase III PEGASUS-TIMI 54 trial has found.
PharmaTimes, 2017-08-24 07:12:35

Novartis breast cancer drug Kisqali wins EU approval
Novartis has announced the launch of its new breast cancer drug Kisqali in the UK today following a green light from European regulators.
PharmaTimes, 2017-08-24 07:07:13

Consumption of EPA and DHA omega-3s reduces cardiac death risk, study shows
Results from a new study published in the Journal of Clinical Lipidology showed that in 14 randomized, controlled trials of 71,899 people, consumption of EPA and DHA omega-3s reduced the risk of cardiac death by a statistically-significant average of 8 percent.
News Medical Life Sciences, 2017-08-24 07:00:44

People who get less REM sleep may have greater dementia risk
People who get less rapid eye movement (REM) sleep may have a greater risk of developing dementia, according to a new study published in the August 23, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. REM sleep is the sleep stage when dreaming occurs.
News Medical Life Sciences, 2017-08-24 03:55:02

Study shows role of exhausted regulatory T cells in allergic reactions
Researchers have evidence that the specialized T cells responsible for maintaining a balanced immune response are vulnerable to exhaustion that disrupts normal functioning and may even contribute to allergic reactions.
News Medical Life Sciences, 2017-08-24 03:42:22

Common obesity and diabetes drug could be used as novel way to lower brain pressure
Research led by the University of Birmingham, published today in Science Translational Medicine, has discovered that a drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel new way to lower brain pressure.
News Medical Life Sciences, 2017-08-24 03:29:00

Variations in ancient mitochondrial DNA may play key role in predisposition to ASD
Mitochondria, the tiny structures inside our cells that generate energy, may play a key role in autism spectrum disorders (ASD).
News Medical Life Sciences, 2017-08-24 03:24:49